Cystinuria

  • Reviewing Rocket Pharmaceuticals (NASDAQ:RCKT) and Retrophin (RTRX) – Fairfield Current
    Read More
  • Jan 04, 2019 marketexclusive.com
    RETROPHIN, INC. (NASDAQ:RTRX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers – Market Exclusive
    Read More
  • Jan 04, 2019 www.modernreaders.com
    Retrophin Inc (RTRX) Shares Sold by Rhumbline Advisers – Modern Readers
    Read More
  • Jan 03, 2019 www.genomeweb.com
    BabySeq Project Uncovers Risk of Childhood-Onset Disease in 9 Percent of Newborns – GenomeWeb
    Read More
  • Jan 02, 2019 finreviewer.com
    $-1.24 EPS Expected for The Scotts Miracle-Gro Company (SMG); Retrophin, Inc. (RTRX) Had 3 Analysts Last Week – The FinReviewer – The FinReviewer
    Read More
  • Jan 01, 2019 pressoracle.com
    Rocket Pharmaceuticals (RCKT) vs. Retrophin (RTRX) Head to Head Analysis – PressOracle
    Read More
  • Dec 20, 2018 www.businesswire.com
    Advicenne Publishes its Financial Calendar for 2019 – Business Wire
    Read More
  • On a diet? A high-protein one may increase your risk of kidney stones – Channel NewsAsia
    Read More
  • Dec 06, 2018 finreviewer.com
    Bogle Investment Management LP Has Increased Its Retrophin Com (RTRX) Holding; Profile of 3 Analysts Covering Kohl’s (KSS) – The FinReviewer
    Read More

Connect. Empower. Inspire.